Mustang Bio (MBIO) Investor Presentation - Slideshow

MB-207 for previously transplanted XSCID (IL2RG) MB-101 CAR-T for GBM (IL13Rα2) Combination CAR-T + oncolytic virus (OV) Expect MB-109 Mustang IND filing 2023 UAB MB-108 Phase 1 ongoing* | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------|----------------------------------------------------------|-----------------------------------------------------------------------------|----------------------------------------------------------|----------------------------------------------------------|----- ...